Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

Protein kinase D1 regulates metabolic switch in pancreatic cancer via modulation of mTORC1.

Kumari S, Khan S, Sekhri R, Mandil H, Behrman S, Yallapu MM, Chauhan SC, Jaggi M.

Br J Cancer. 2019 Dec 10. doi: 10.1038/s41416-019-0629-9. [Epub ahead of print]

PMID:
31819177
2.

Autoimmune encephalitis in the elderly: who to test and what to test for.

Behrman S, Lennox B.

Evid Based Ment Health. 2019 Nov;22(4):172-176. doi: 10.1136/ebmental-2019-300110. Epub 2019 Sep 19. Review.

PMID:
31537612
3.

Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.

Ecker BL, Vollmer CM Jr, Behrman SW, Allegrini V, Aversa J, Ball CG, Barrows CE, Berger AC, Cagigas MN, Christein JD, Dixon E, Fisher WE, Freedman-Weiss M, Guzman-Pruneda F, Hollis RH, House MG, Kent TS, Kowalsky SJ, Malleo G, Salem RR, Salvia R, Schmidt CR, Seykora TF, Zheng R, Zureikat AH, Dickson PV.

JAMA Surg. 2019 May 29. doi: 10.1001/jamasurg.2019.1170. [Epub ahead of print]

PMID:
31141112
4.

Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer.

Khan S, Setua S, Kumari S, Dan N, Massey A, Hafeez BB, Yallapu MM, Stiles ZE, Alabkaa A, Yue J, Ganju A, Behrman S, Jaggi M, Chauhan SC.

Biomaterials. 2019 Jul;208:83-97. doi: 10.1016/j.biomaterials.2019.04.005. Epub 2019 Apr 8.

PMID:
30999154
5.

Pancreatic Adenocarcinoma, Version 1.2019.

Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, Fountzilas C, Wolpin BM, Al-Hawary M, Asbun H, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chung V, Dillhoff M, Dotan E, Ferrone CR, Fisher G, Hardacre J, Hawkins WG, Ko AH, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Thayer S, Wolff RA, Burns JL, Zuccarino-Catania G.

J Natl Compr Canc Netw. 2019 Mar 1;17(3):202-210. doi: 10.6004/jnccn.2019.0014.

PMID:
30865919
6.

Hypervascular lesions of the pancreas: Think before you act.

Wcislak SM, Stiles ZE, Deneve JL, Glazer ES, Behrman SW, Farooq FT, Dickson PV.

Am J Surg. 2019 Aug;218(2):362-367. doi: 10.1016/j.amjsurg.2018.11.021. Epub 2018 Nov 27.

PMID:
30509457
7.

Long-Term Implications of Unplanned Conversion During Laparoscopic Liver Resection for Hepatocellular Carcinoma.

Stiles ZE, Glazer ES, Deneve JL, Shibata D, Behrman SW, Dickson PV.

Ann Surg Oncol. 2019 Jan;26(1):282-289. doi: 10.1245/s10434-018-7073-6. Epub 2018 Nov 19.

PMID:
30456682
8.

Prescribing antipsychotics in older people: A mini-review.

Behrman S, Burgess J, Topiwala A.

Maturitas. 2018 Oct;116:8-10. doi: 10.1016/j.maturitas.2018.06.015. Epub 2018 Jul 23. Review.

PMID:
30244784
9.

Outcomes Following Resection of Hepatocellular Carcinoma in the Absence of Cirrhosis.

Lewis RH, Glazer ES, Bittenbinder DM, O'Brien T, Deneve JL, Shibata D, Behrman SW, Vanatta JM, Satapathy SK, Dickson PV.

J Gastrointest Cancer. 2019 Dec;50(4):808-815. doi: 10.1007/s12029-018-0152-x.

PMID:
30117090
10.

Transmembrane mucin MUC13 distinguishes intraductal papillary mucinous neoplasms from non-mucinous cysts and is associated with high-risk lesions.

Stiles ZE, Khan S, Patton KT, Jaggi M, Behrman SW, Chauhan SC.

HPB (Oxford). 2019 Jan;21(1):87-95. doi: 10.1016/j.hpb.2018.07.009. Epub 2018 Aug 14.

PMID:
30115565
11.

Desmoplastic small round cell tumor: A nationwide study of a rare sarcoma.

Stiles ZE, Dickson PV, Glazer ES, Murphy AJ, Davidoff AM, Behrman SW, Bishop MW, Martin MG, Deneve JL.

J Surg Oncol. 2018 Jun;117(8):1759-1767. doi: 10.1002/jso.25071. Epub 2018 Jun 7.

PMID:
29878371
12.

The impact of unplanned conversion to an open procedure during minimally invasive pancreatectomy.

Stiles ZE, Dickson PV, Deneve JL, Glazer ES, Dong L, Wan JY, Behrman SW.

J Surg Res. 2018 Jul;227:168-177. doi: 10.1016/j.jss.2018.02.028. Epub 2018 Mar 19.

PMID:
29804849
13.

Ampullary adenocarcinoma: Defining predictors of survival and the impact of adjuvant therapy following surgical resection for stage I disease.

Stiles ZE, Behrman SW, Deneve JL, Glazer ES, Dong L, Wan JY, Martin MG, Dickson PV.

J Surg Oncol. 2018 Jun;117(7):1500-1508. doi: 10.1002/jso.25021. Epub 2018 Mar 8.

PMID:
29518820
14.

Molecular Alterations Associated with DNA Repair in Pancreatic Adenocarcinoma Are Associated with Sites of Recurrence.

Ferguson MD, Dong L, Wan J, Deneve JL, Dickson PV, Behrman SW, Shibata D, Martin MG, Glazer ES.

J Gastrointest Cancer. 2019 Jun;50(2):285-291. doi: 10.1007/s12029-018-0073-8.

PMID:
29427136
15.

Clinical significance of MUC13 in pancreatic ductal adenocarcinoma.

Khan S, Zafar N, Khan SS, Setua S, Behrman SW, Stiles ZE, Yallapu MM, Sahay P, Ghimire H, Ise T, Nagata S, Wang L, Wan JY, Pradhan P, Jaggi M, Chauhan SC.

HPB (Oxford). 2018 Jun;20(6):563-572. doi: 10.1016/j.hpb.2017.12.003. Epub 2018 Jan 17.

16.

Diagnosing and managing mild cognitive impairment.

Behrman S, Valkanova V, Allan CL.

Practitioner. 2017 May;261(1804):17-20. Review.

PMID:
29120563
17.

Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group.

Ecker BL, McMillan MT, Allegrini V, Bassi C, Beane JD, Beckman RM, Behrman SW, Dickson EJ, Callery MP, Christein JD, Drebin JA, Hollis RH, House MG, Jamieson NB, Javed AA, Kent TS, Kluger MD, Kowalsky SJ, Maggino L, Malleo G, Valero V 3rd, Velu LKP, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

Ann Surg. 2019 Jan;269(1):143-149. doi: 10.1097/SLA.0000000000002491.

PMID:
28857813
18.

Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies.

Ecker BL, McMillan MT, Maggino L, Allegrini V, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Bloomston M, Callery MP, Christein JD, Dickson E, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, Salem RR, Soares KC, Valero V 3rd, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

J Gastrointest Surg. 2018 Jan;22(1):68-76. doi: 10.1007/s11605-017-3547-2. Epub 2017 Aug 24. No abstract available.

PMID:
28840459
19.

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, Benson AB 3rd, Binder E, Cardin DB, Cha C, Chiorean EG, Chung V, Czito B, Dillhoff M, Dotan E, Ferrone CR, Hardacre J, Hawkins WG, Herman J, Ko AH, Komanduri S, Koong A, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Scaife C, Thayer S, Weekes CD, Wolff RA, Wolpin BM, Burns J, Darlow S.

J Natl Compr Canc Netw. 2017 Aug;15(8):1028-1061. doi: 10.6004/jnccn.2017.0131.

PMID:
28784865
20.

Predictors and implications of unplanned conversion during minimally invasive hepatectomy: an analysis of the ACS-NSQIP database.

Stiles ZE, Behrman SW, Glazer ES, Deneve JL, Dong L, Wan JY, Dickson PV.

HPB (Oxford). 2017 Nov;19(11):957-965. doi: 10.1016/j.hpb.2017.06.012. Epub 2017 Jul 29.

21.

A Prospective Randomized Multicenter Trial of Distal Pancreatectomy With and Without Routine Intraperitoneal Drainage.

Van Buren G 2nd, Bloomston M, Schmidt CR, Behrman SW, Zyromski NJ, Ball CG, Morgan KA, Hughes SJ, Karanicolas PJ, Allendorf JD, Vollmer CM Jr, Ly Q, Brown KM, Velanovich V, Winter JM, McElhany AL, Muscarella P 2nd, Schmidt CM, House MG, Dixon E, Dillhoff ME, Trevino JG, Hallet J, Coburn NSG, Nakeeb A, Behrns KE, Sasson AR, Ceppa EP, Abdel-Misih SRZ, Riall TS, Silberfein EJ, Ellison EC, Adams DB, Hsu C, Tran Cao HS, Mohammed S, VillafaƱe-Ferriol N, Barakat O, Massarweh NN, Chai C, Mendez-Reyes JE, Fang A, Jo E, Mo Q, Fisher WE.

Ann Surg. 2017 Sep;266(3):421-431. doi: 10.1097/SLA.0000000000002375.

PMID:
28692468
22.

Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy.

Ecker BL, McMillan MT, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Dickson EJ, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Javed AA, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, Poruk KE, Salem RR, Schmidt CR, Soares K, Stauffer JA, Valero V, Velu LKP, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

Ann Surg. 2018 Apr;267(4):608-616. doi: 10.1097/SLA.0000000000002327.

PMID:
28594741
23.

Management and outcomes following pancreaticoduodenectomy for ampullary adenocarcinoma.

Chavez MT, Sharpe JP, O'Brien T, Patton KT, Portnoy DC, VanderWalde NA, Deneve JL, Shibata D, Behrman SW, Dickson PV.

Am J Surg. 2017 Nov;214(5):856-861. doi: 10.1016/j.amjsurg.2017.01.029. Epub 2017 Jan 30.

PMID:
28285709
24.

Does Hyperbilirubinemia Contribute to Adverse Patient Outcomes Following Pancreatoduodenectomy?

Dolejs S, Zarzaur BL, Zyromski NJ, Pitt HA, Riall TS, Hall BL, Behrman SW.

J Gastrointest Surg. 2017 Apr;21(4):647-656. doi: 10.1007/s11605-017-3381-6. Epub 2017 Feb 15.

PMID:
28205125
25.

Diagnosing early cognitive decline-When, how and for whom?

Allan CL, Behrman S, Ebmeier KP, Valkanova V.

Maturitas. 2017 Feb;96:103-108. doi: 10.1016/j.maturitas.2016.11.018. Epub 2016 Dec 1. Review.

PMID:
28041588
26.

Patient safety in community dementia services: what can we learn from the experiences of caregivers and healthcare professionals?

Behrman S, Wilkinson P, Lloyd H, Vincent C.

Age Ageing. 2017 May 1;46(3):518-521. doi: 10.1093/ageing/afw220.

PMID:
27932369
27.

Pancreas fistula risk prediction: implications for hospital costs and payments.

Abbott DE, Tzeng CW, McMillan MT, Callery MP, Kent TS, Christein JD, Behrman SW, Schauer DP, Hanseman DJ, Eckman MH, Vollmer CM.

HPB (Oxford). 2017 Feb;19(2):140-146. doi: 10.1016/j.hpb.2016.10.016. Epub 2016 Nov 21.

28.

miRNA nanotherapeutics for cancer.

Ganju A, Khan S, Hafeez BB, Behrman SW, Yallapu MM, Chauhan SC, Jaggi M.

Drug Discov Today. 2017 Feb;22(2):424-432. doi: 10.1016/j.drudis.2016.10.014. Epub 2016 Nov 1. Review.

29.

Driving and dementia: a clinical update for mental health professionals.

Allan CL, Behrman S, Baruch N, Ebmeier KP.

Evid Based Ment Health. 2016 Nov;19(4):110-113. doi: 10.1136/eb-2016-102485. Epub 2016 Oct 20.

PMID:
27765792
30.

Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management.

Weatherall T, Denbo J, Sharpe J, Martin M, O'Brien T, Gupta R, Groshart K, Behrman S, Dickson P.

World J Surg. 2017 Mar;41(3):844-850. doi: 10.1007/s00268-016-3770-0.

PMID:
27743074
31.

Externalized Stents for Pancreatoduodenectomy Provide Value Only in High-Risk Scenarios.

McMillan MT, Ecker BL, Behrman SW, Callery MP, Christein JD, Drebin JA, Fraker DL, Kent TS, Lee MK, Roses RE, Sprys MH, Vollmer CM Jr.

J Gastrointest Surg. 2016 Dec;20(12):2052-2062. Epub 2016 Oct 11.

PMID:
27730401
32.

Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy.

Setua S, Khan S, Yallapu MM, Behrman SW, Sikander M, Khan SS, Jaggi M, Chauhan SC.

J Gastrointest Surg. 2017 Jan;21(1):94-105. doi: 10.1007/s11605-016-3222-z. Epub 2016 Aug 9.

33.

MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression.

Khan S, Sikander M, Ebeling MC, Ganju A, Kumari S, Yallapu MM, Hafeez BB, Ise T, Nagata S, Zafar N, Behrman SW, Wan JY, Ghimire HM, Sahay P, Pradhan P, Chauhan SC, Jaggi M.

Oncogene. 2017 Jan 26;36(4):491-500. doi: 10.1038/onc.2016.218. Epub 2016 Jun 20.

34.

Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy.

McMillan MT, Allegrini V, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Bloomston M, Callery MP, Christein JD, Dickson E, Dixon E, Drebin JA, Fernandez-Del Castillo C, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, McElhany AL, Salem RR, Soares KC, Sprys MH, Valero V 3rd, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

Ann Surg. 2017 May;265(5):978-986. doi: 10.1097/SLA.0000000000001796.

PMID:
27232260
35.

PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.

Nagesh PKB, Johnson NR, Boya VKN, Chowdhury P, Othman SF, Khalilzad-Sharghi V, Hafeez BB, Ganju A, Khan S, Behrman SW, Zafar N, Chauhan SC, Jaggi M, Yallapu MM.

Colloids Surf B Biointerfaces. 2016 Aug 1;144:8-20. doi: 10.1016/j.colsurfb.2016.03.071. Epub 2016 Mar 26.

36.

Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation.

McMillan MT, Soi S, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, House MG, Hughes SJ, Kent TS, Kunstman JW, Malleo G, Miller BC, Salem RR, Soares K, Valero V, Wolfgang CL, Vollmer CM Jr.

Ann Surg. 2016 Aug;264(2):344-52. doi: 10.1097/SLA.0000000000001537.

PMID:
26727086
37.

Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy.

McMillan MT, Christein JD, Callery MP, Behrman SW, Drebin JA, Hollis RH, Kent TS, Miller BC, Sprys MH, Watkins AA, Strasberg SM, Vollmer CM Jr.

Surgery. 2016 Apr;159(4):1013-22. doi: 10.1016/j.surg.2015.10.028. Epub 2015 Dec 6.

PMID:
26670325
38.

Follicular pancreatitis: a distinct form of chronic pancreatitis-an additional mimic of pancreatic neoplasms.

Gupta RK, Xie BH, Patton KT, Lisovsky M, Burks E, Behrman SW, Klimstra D, Deshpande V.

Hum Pathol. 2016 Feb;48:154-62. doi: 10.1016/j.humpath.2015.09.017. Epub 2015 Oct 3.

39.

Surgical management of complicated pancreatic pseudocysts after acute pancreatitis.

Marino KA, Hendrick LE, Behrman SW.

Am J Surg. 2016 Jan;211(1):109-14. doi: 10.1016/j.amjsurg.2015.07.020. Epub 2015 Oct 24.

PMID:
26507289
40.

The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy.

McMillan MT, Vollmer CM Jr, Asbun HJ, Ball CG, Bassi C, Beane JD, Berger AC, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, House MG, Hughes SJ, Kent TS, Kunstman JW, Malleo G, McElhany AL, Salem RR, Soares K, Sprys MH, Valero V 3rd, Watkins AA, Wolfgang CL, Behrman SW.

J Gastrointest Surg. 2016 Feb;20(2):262-76. doi: 10.1007/s11605-015-2884-2. Epub 2015 Jul 11.

PMID:
26162925
41.

Effect of ageing on keratoconic corneas.

Millodot M, Ortenberg I, Lahav-Yacouel K, Behrman S.

J Optom. 2016 Apr-Jun;9(2):72-7. doi: 10.1016/j.optom.2015.05.001. Epub 2015 Jul 2.

42.

Be vigilant for perinatal mental health problems.

Cristescu T, Behrman S, Jones SV, Chouliaras L, Ebmeier KP.

Practitioner. 2015 Mar;259(1780):19-23, 2-3. Review.

PMID:
26062269
43.

Nanoparticle formulation of ormeloxifene for pancreatic cancer.

Khan S, Chauhan N, Yallapu MM, Ebeling MC, Balakrishna S, Ellis RT, Thompson PA, Balabathula P, Behrman SW, Zafar N, Singh MM, Halaweish FT, Jaggi M, Chauhan SC.

Biomaterials. 2015;53:731-43. doi: 10.1016/j.biomaterials.2015.02.082. Epub 2015 Mar 26.

44.

Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer.

Khan S, Ebeling MC, Chauhan N, Thompson PA, Gara RK, Ganju A, Yallapu MM, Behrman SW, Zhao H, Zafar N, Singh MM, Jaggi M, Chauhan SC.

Cancer Res. 2015 Jun 1;75(11):2292-304. doi: 10.1158/0008-5472.CAN-14-2397. Epub 2015 Apr 3. Erratum in: Cancer Res. 2018 May 1;78(9):2444.

45.

Quantifying the burden of complications following total pancreatectomy using the postoperative morbidity index: a multi-institutional perspective.

Datta J, Lewis RS Jr, Strasberg SM, Hall BL, Allendorf JD, Beane JD, Behrman SW, Callery MP, Christein JD, Drebin JA, Epelboym I, He J, Pitt HA, Winslow E, Wolfgang C, Lee MK 4th, Vollmer CM Jr.

J Gastrointest Surg. 2015 Mar;19(3):506-15. doi: 10.1007/s11605-014-2706-y. Epub 2014 Dec 2.

PMID:
25451733
46.

MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer.

Khan S, Ebeling MC, Zaman MS, Sikander M, Yallapu MM, Chauhan N, Yacoubian AM, Behrman SW, Zafar N, Kumar D, Thompson PA, Jaggi M, Chauhan SC.

Oncotarget. 2014 Sep 15;5(17):7599-609.

47.

Establishing a quantitative benchmark for morbidity in pancreatoduodenectomy using ACS-NSQIP, the Accordion Severity Grading System, and the Postoperative Morbidity Index.

Vollmer CM Jr, Lewis RS, Hall BL, Allendorf JD, Beane JD, Behrman SW, Callery MP, Christein JD, Drebin JA, Epelboym I, He J, Pitt HA, Winslow E, Wolfgang C, Strasberg SM.

Ann Surg. 2015 Mar;261(3):527-36. doi: 10.1097/SLA.0000000000000843.

PMID:
25268299
48.

The value of drains as a fistula mitigation strategy for pancreatoduodenectomy: something for everyone? Results of a randomized prospective multi-institutional study.

McMillan MT, Fisher WE, Van Buren G 2nd, McElhany A, Bloomston M, Hughes SJ, Winter J, Behrman SW, Zyromski NJ, Velanovich V, Brown K, Morgan KA, Vollmer C.

J Gastrointest Surg. 2015 Jan;19(1):21-30; discussion 30-1. doi: 10.1007/s11605-014-2640-z. Epub 2014 Sep 3.

PMID:
25183409
49.

Routine drainage of the operative bed following elective distal pancreatectomy does not reduce the occurrence of complications.

Behrman SW, Zarzaur BL, Parmar A, Riall TS, Hall BL, Pitt HA.

J Gastrointest Surg. 2015 Jan;19(1):72-9; discussion 79. doi: 10.1007/s11605-014-2608-z. Epub 2014 Aug 13.

50.

Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.

Tempero MA, Malafa MP, Behrman SW, Benson AB 3rd, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Lowy AM, Ma WW, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Reddy S, Sasson AR, Thayer SP, Weekes CD, Wolff RA, Wolpin BM, Burns JL, Freedman-Cass DA.

J Natl Compr Canc Netw. 2014 Aug;12(8):1083-93.

PMID:
25099441

Supplemental Content

Loading ...
Support Center